The role of continuous glucose monitoring in holistic diabetes management
Continuous glucose monitoring (CGM) technologies have transformed diabetes management by providing real-time, accurate glucose readings. These systems make it easier for individuals to track how their diet and lifestyle affect their glucose levels,
Glucose monitors for diabetes have finally been funded – but there's a problem
There are problems within the health system that mean full patient access to training on how to use the insulin pumps will likely take years, experts say.
Mercy Places First Commercial Eversense 365: The World’s First and Only 365-Day Continuous Glucose Monitor
Senseonics’ Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2
Continuous Glucose Monitoring Systems Market Insights, Advances in Diabetes Management, 2024 to 2032
The global continuous glucose monitoring systems (CGMS) market was valued at approximately USD 6,626.6 million in 2021 and is expected to grow to USD 31,708.2 million by 2032, with a CAGR of 17.0% from 2022 to 2032. Request To Download Free Sample of This Strategic Report @ https://reportocean.com/industry-verticals/sample-request?report_id=bw9958
New integrated continuous glucose monitor developed
A “fully integrated, wearable” continuous glucose monitor (CGM) is set to transform diabetes care, researchers have said. Scientists from the University of Hong Kong, Zhejiang University and Guangzhou Medical University have developed a new CGM that is set to have better anti-noise ability, reliability, and wearability compared to other devices.
Continuous glucose monitors 'life-changing' for children with type 1 diabetes
The monitors - which Pharmac is now funding for all type 1 diabetics - mean patients are less likely to suffer early deaths, researcher says.
Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits
To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that happens, newly-funded health technologies won’t get to those most in need.
USA Today3d
Diabetics use glucose monitors. Should non-diabetics use them too?
TUCSON, Ariz. – The continuous glucose monitor pierced my skin so quickly I can barely recall the sensation. A prick? A poke? A prod? In my case, Eric Williamson, director of nutrition at ...
Medical Xpress29d
Team develops next-generation wearable continuous glucose monitoring system for diabetes management
Their research has been published in Science Advances, titled "Coin-sized, fully integrated, and minimally invasive continuous glucose monitoring system based on organic electrochemical transistors.
WISH-TV5d
How continuous glucose monitoring is changing health management
highlighting a breakthrough in continuous glucose monitoring that could change how we approach metabolic health. Most of us associate glucose monitoring with diabetes management, but Pam ...
Nasdaq13d
Expanding Continuous Glucose Monitoring Options: How Glucotrack Is Helping Usher In The Next Generation Of Diabetes Care Technology
Abbott Laboratories (NYSE: ABT) has established a strong presence in diabetes management with its CGM system, FreeStyle Libre. Libre offers accurate and continuous glucose monitoring, but the ...
clinicaladvisor.com6d
Cases of Adverse Mental Health Outcomes Developing With Continuous Glucose Monitoring
The study author endorses preassessment and providing psychoeducation or combining CGM initiation with therapy, mindfulness, ...
Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...
Abbott reports sales of $10.6bn for Q3 2024
Abbott Laboratories has reported sales of $10.6bn for the third quarter (Q3) of 2024, as against $10.4bn in Q2 2024, with ...
Abbott Q3: Strong Growth In Medical Device And Pharma
Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...